Annual report pursuant to Section 13 and 15(d)

SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) (Parenthetical)

v3.22.1
SCHEDULE OF DILUTIVE COMMON STOCK EQUIVALENTS (Details) (Parenthetical) - USD ($)
12 Months Ended
May 27, 2021
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Shares issued upon conversion 100,000  
Stock conversion amount $ 350,000  
Convertible Notes Payable One [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Shares issued upon conversion   1,245,468
Stock conversion amount   $ 1,294,268
Equity Method Investment, Ownership Percentage   4.99%